European Patent Office

T 0411/02 (CTL4A receptor/BRISTOL-MYERS SQUIBB) vom 07.11.2006

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2006:T041102.20061107
Datum der Entscheidung
7. November 2006
Aktenzeichen
T 0411/02
Antrag auf Überprüfung von
-
Anmeldenummer
92914009.3
IPC-Klasse
C12N 15/62
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
CTL4A Receptor, fusion proteins containing it and uses thereof
Name des Antragstellers
Bristol-Myers Squibb Company
Name des Einsprechenden
Genetics Institute
Kammer
3.3.04
Leitsatz
-
Schlagwörter
Admissibility of the appeals (yes)
Admission into the proceedings of documents (yes)
Admission into the proceedings of requests (yes)
Main request - added matter (yes)
Auxiliary request 1 - extention of scope of protection (yes)
Auxiliary request 2b - added matter, extention of scope of protection (no), clarity, sufficiency, novelty, inventive step (yes)
Orientierungssatz
-
Zitierende Akten
T 0305/07

ORDER

For these reasons it is decided that:

1. The appeal of appellant I is admissible.

2. The decision under appeal is set aside.

3. The case is remitted to the department of first instance with the order to maintain the patent on the basis of:

- claims 1-12 of the New Auxiliary request 2b (AT, BE, ...) submitted on 6 November 2006 at the oral proceedings, for all designated states except GR and ES,

- claims 1-12 of Auxiliary Request 2b (GR), submitted on 7 November 2006 at the oral proceedings, for GR,

- claims 1-12 of Auxiliary Request 2b (ES), submitted on 7 November 2006 at the oral proceedings, for ES,

- amended pages 3, 3a, 4 and 9 of the description of EP 0 606 217 B1 dated 7 November 2006,

- pages 2, 5-8, 10-25 of the patent EP 0 606 217 B1,

- figures 1-10 of the patent EP 0 606 217 B1.